First Time Loading...

Bristol-Myers Squibb Co
NYSE:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
NYSE:BMY
Watchlist
Price: 44.705 USD -8.5% Market Closed
Updated: Apr 25, 2024

Wall Street
Price Targets

BMY Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BMY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BMY is 57.071 USD with a low forecast of 40.4 USD and a high forecast of 78.75 USD.

Lowest
Price Target
40.4 USD
10% Downside
Average
Price Target
57.071 USD
28% Upside
Highest
Price Target
78.75 USD
76% Upside

BMY Last Price Targets
Bristol-Myers Squibb Co

The latest public price target was made on Jan 30, 2024 by James Shin from Deutsche Bank , who expects BMY stock to rise by 23% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
James Shin
Deutsche Bank
55 USD
Upside 23%
2 months ago
Jan 30, 2024
Did You Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts?
Benzinga
Evan Seigerman
BMO Capital
60 USD
Upside 34%
4 months ago
Nov 27, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Benzinga
David Risinger
Leerink Partners
66 USD
Upside 48%
6 months ago
Oct 12, 2023
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Benzinga
Louise Chen
Cantor Fitzgerald
75 USD
Upside 68%
7 months ago
Sep 6, 2023
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low
Benzinga
James Shin
Deutsche Bank
Price Target 55 USD
Upside/Downside 23%
View Source
Evan Seigerman
BMO Capital
Price Target 60 USD
Upside/Downside 34%
View Source
David Risinger
Leerink Partners
Price Target 66 USD
Upside/Downside 48%
View Source
Louise Chen
Cantor Fitzgerald
Price Target 75 USD
Upside/Downside 68%
View Source
Bristol-Myers Squibb Co Competitors:
Price Targets
460
Sihuan Pharmaceutical Holdings Group Ltd
407% Upside
002349
Jinghua Pharmaceutical Group Co Ltd
302% Upside
600195
China Animal Husbandry Industry Co Ltd
66% Upside
STAR
Strides Pharma Science Ltd
4% Downside
4887
Sawai Group Holdings Co Ltd
4% Upside
300497
Jiangxi Fushine Pharmaceutical Co Ltd
210% Upside
RX
Biosyent Inc
8% Upside
JNJ
Johnson & Johnson
22% Upside

Revenue
Forecast

Revenue Estimate
Bristol-Myers Squibb Co

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 13%. The projected CAGR for the next 3 years is 0%.

13%
Past Growth
0%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bristol-Myers Squibb Co

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 23%. The projected CAGR for the next 3 years is 14%.

23%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-37%
Average Miss

Net Income
Forecast

Net Income Estimate
Bristol-Myers Squibb Co

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's net income is 23%. The projected CAGR for the next 3 years is 19%.

23%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-57%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BMY's stock price target?
Price Target
57.071 USD

According to Wall Street analysts, the average 1-year price target for BMY is 57.071 USD with a low forecast of 40.4 USD and a high forecast of 78.75 USD.

What is Bristol-Myers Squibb Co's Revenue forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's revenue is 13%. The projected CAGR for the next 3 years is 0%.

What is Bristol-Myers Squibb Co's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's operating income is 23%. The projected CAGR for the next 3 years is 14%.

What is Bristol-Myers Squibb Co's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Bristol-Myers Squibb Co's net income is 23%. The projected CAGR for the next 3 years is 19%.